Pliant Therapeutics files initial beneficial ownership statement for Chief Medical Officer David Raben
PLRX•Pliant Therapeutics filed a Form 3 for Chief Medical Officer David Raben, dated Sept. 30, 2026.
1. Ownership filing
Pliant Therapeutics filed a Form 3 for Chief Medical Officer David Raben, dated Sept. 30, 2026.
